Search Results

You are looking at 71 - 80 of 438 items for :

  • "Adjuvant therapy" x
Clear All
Full access

Margaret Tempero

margin,” she said. Dr. Tempero briefly reviewed some of the representative adjuvant therapy clinical trials conducted in pancreatic cancer, focusing primarily on the relatively recent phase III ESPAC-4 trial of gemcitabine/capecitabine 1 and the

Full access

Margaret Tempero

reason that in the adjuvant setting, we could probably identify diagnostic tools to predict outcome, and thus need for adjuvant treatment, across all disease sites. Actually, folks are working on that with a fair bit of success. But adjuvant therapy is

Full access

Carcinoma Lake Alison M. MD Roberts William W. MD 11 2006 4 4 10 10 1015 1015 1018 1018 0041015 10.6004/jnccn.2006.0084 Importance of Node Dissection in Relation to Neoadjuvant and Adjuvant Therapy Huang William C. MD Bochner

Full access

0050884 10.6004/jnccn.2007.0079 Adjuvant Therapy for Stage II Colon Cancer: Prognostic and Predictive Markers Vicuna Brian MD Benson Al B. III MD 10 2007 5 5 9 9 927 927 936 936 0050927 10.6004/jnccn.2007.0080 Rectal Cancer 10 2007

Full access

, and Prediction of Response Gold Michael A. MD 01 2008 6 6 1 1 37 37 45 45 0060037 10.6004/jnccn.2008.0004 Primary Management of Early Stage Cervical Cancer (IA1-IB) and Appropriate Selection of Adjuvant Therapy Gray Heidi J. MD 01

Full access

Michaela J. Higgins, James M. Rae, David A. Flockhart, Daniel F. Hayes and Vered Stearns

adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial . Lancet Oncol 2008 ; 9 : 45 – 53 . 48 Coates AS Keshaviah A Thurlimann B . Five years of letrozole compared with tamoxifen as initial adjuvant therapy for

Full access

John A. Thompson

-positives. PET/CT may be more useful than conventional CT in the workup of patients who have relatively high pretest probabilities of occult metastatic disease (eg, patients with stage IIIB and IIIC melanoma). Treatment Adjuvant Therapy High

Full access

We With Adjuvant Therapy of Stage III and IV Melanoma in 2009? Fecher Leslie A. MD Flaherty Keith T. MD 3 2009 7 7 3 3 295 295 304 304 10.6004/jnccn.2009.0022 Role of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma

Full access

Wells A. Messersmith

treatment with the best chance of success. Adjuvant Therapy Although 11 agents have been approved by the FDA for CRC, only 3 are used in the adjuvant setting (fluorouracil [5-FU], capecitabine, and oxaliplatin) and only 2 (cetuximab and panitumumab

Full access

Accepted? Li Edward C. PharmD, BCOP 7 2011 9 9 7 7 696 696 699 699 0090696 10.6004/jnccn.2011.0060 Does Use of the Adjuvant! Model Influence Use of Adjuvant Therapy Through Better Risk Communication? Belkora Jeffrey K. a PhD Hutton